Racial/Ethnic Disparities in Life Years Lost (LYL) to Type 2 Diabetes (T2D) in Medicare Beneficiaries in the United States

被引：0
|
作者：
Wang, Yu
Shao, Yixue
Cheng, Yiling
Imperatore, Giuseppina
Luman, Elizabeth
Holliday, Christopher S.
Zhang, Ping
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-1258-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1258-P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Neural Network to Identifying Type 2 Diabetes (T2D) Progression Subphenotypes
    Huang, Yu
    Fan, Zhengkang
    Donahoo, William T.
    Guo, Jingchuan
    Bian, Jiang
    DIABETES, 2024, 73
  • [42] Subgroups of Type 2 Diabetes (T2D) by Clinical Features and Islet Autoimmunity
    Pilla, Scott J.
    Knowler, William C.
    Balasubramanyam, Ashok
    Hampe, Christiane S.
    Pietropaolo, Susan
    Lin, Darren
    Anderson, Andrea M.
    Zhao, Ni
    Lernmark, Ake
    Mathioudakis, Nestoras N.
    Bancks, Michael
    Clark, Jeanne
    Maruthur, Nisa M.
    DIABETES, 2024, 73
  • [43] Outcomes of Type 2 Diabetes (T2D) Clustering Replicated in the DEVOTE Trial
    Kahkoska, Anna R.
    Hachmann-Nielsen, Elise
    Klein, Klara
    Kongsbak, Kristine G.
    Kvist, Kajsa
    Buse, John B.
    DIABETES, 2019, 68
  • [44] Children with Type 2 Diabetes (T2D) Have Altered Arginine Metabolism
    Tosur, Mustafa
    Hsu, Jean W.
    Deen, Saima
    Uysal, Serife
    Astudillo, Marcela
    Redondo, Maria J.
    Jahoor, Farook
    Balasubramanyam, Ashok
    DIABETES, 2022, 71
  • [45] The Gut Microbiome and Puberty in Girls at Risk for Type 2 Diabetes (T2D)
    Jobira, Beza
    Frank, Daniel N.
    Pyle, Laura
    Gross, Susan
    Ir, Diana
    Pendleton, Wesley
    Robertson, Charles E.
    Nadeau, Kristen J.
    Kelsey, Megan M.
    DIABETES, 2019, 68
  • [46] Mechanisms of the Antihyperglycemic Effect of Sitagliptin in Patients with Type 2 Diabetes (T2D)
    Muscelli, Elza
    Casolaro, Arturo
    Gastaldelli, Amalia
    Mari, Andrea
    Seghieri, Giuseppe
    Chen, Yu
    Alba, Maria
    Holst, Jens
    Ferrannini, Ele
    DIABETES, 2011, 60 : A267 - A267
  • [47] Effectiveness of a screening program of type 2 diabetes (T2D) in Primary Care, and long-term incidence of T2D in Spain
    Gabriel, R.
    Vazquez-Fernandez, A.
    Marques, P.
    Novella, B.
    Moreno, S.
    Vega, S.
    Gonzalvez, L.
    Arranz, M.
    Melero, M. C.
    Montero Herrero, M. R.
    Acosta Vergara, T.
    Tuomilehto, J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [48] Dapagliflozin (DAPA) in Patients with Type 2 Diabetes (T2D) and Mixed Dyslipidemia
    Bays, Harold E.
    Sartipy, Peter
    Xu, John
    Langkilde, Anna Maria
    Sjostrom, C. David
    DIABETES, 2016, 65 : A306 - A306
  • [49] Renal Impairment and Antidiabetic Medication Use in Type 2 Diabetes (T2D)
    Koro, Carol E.
    Stender, Monika
    Sowell, Margaret
    Bourgeois, Nancy
    Spain, C. Victor
    DIABETES, 2014, 63 : A636 - A636
  • [50] Genomic Data and Disease Forecasting: Application to Type 2 Diabetes (T2D)
    Sirovich, Lawrence
    PLOS ONE, 2014, 9 (01):
12345